NCT00091507View on ClinicalTrials.gov

IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.

PHASE3CompletedINTERVENTIONAL
Enrollment

911

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2012

Conditions
Angina, UnstableCardiovascular DiseasesHeart DiseasesCoronary DiseaseMyocardial InfarctionHeart Failure, Congestive
Interventions
DRUG

GIK

Intravenous solution, 1.5ml/kg/hour, continuous infusion for total of 12 hours.

DRUG

Placebo

Intravenous solution of Dextrose 5 percent at 1.5 ml/kg/hour for a total of 12 hours.

Trial Locations (13)

17033

Hershey Site, Hershey

31208

Macon Site, Macon

53226

Milwaukee Site, Milwaukee

55128

St. Paul Site, Saint Paul

57104

Sioux Falls Site, Sioux Falls

75201

Dallas Site, Dallas

79905

El Paso Site, El Paso

87131

Albuquerque Site, Albuquerque

98225

Bellingham Site, Bellingham

99501

Anchorage Site, Anchorage

06511

New Haven Site, New Haven

02301

Brockton Site, Brockton

01742

Concord Site, Concord

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Tufts Medical Center

OTHER

NCT00091507 - IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium. | Biotech Hunter | Biotech Hunter